Chengwen Li active positions
| Companies | Position | Start | End |
|---|---|---|---|
GeneVentiv Therapeutics, Inc.
 GeneVentiv Therapeutics, Inc. BiotechnologyHealth Technology GeneVentiv Therapeutics, Inc. is a company that is developing the first gene therapy for patients with hemophilia A or B, with or without inhibitors. The company is based in Raleigh, NC. The company's product, Genv-Hem, produces clotting factor Va, which allows for normal clotting in response to injury. Currently, there are no curative gene therapies available for patients with inhibitors. GeneVentiv Therapeutics was founded by Chengwen Li and the CEO is Damon R Race. | Founder | - | - |
| Corporate Officer/Principal | - | - | |
| Nabgen, Inc. | Director/Board Member | - | - |
Career history of Chengwen Li
Statistics
International
| United States | 3 |
Operational
| Founder | 1 |
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
Sectoral
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
GeneVentiv Therapeutics, Inc.
GeneVentiv Therapeutics, Inc. BiotechnologyHealth Technology GeneVentiv Therapeutics, Inc. is a company that is developing the first gene therapy for patients with hemophilia A or B, with or without inhibitors. The company is based in Raleigh, NC. The company's product, Genv-Hem, produces clotting factor Va, which allows for normal clotting in response to injury. Currently, there are no curative gene therapies available for patients with inhibitors. GeneVentiv Therapeutics was founded by Chengwen Li and the CEO is Damon R Race. | Health Technology |
| Nabgen, Inc. |
- Stock Market
- Insiders
- Chengwen Li
- Experience
